Q2 2024 Sangamo Therapeutics Inc Earnings Call

Yahoo FinanceAug 7 13:24 ET

Earnings Call: Sangamo Therapeutics Extends Cash Runway Into 2025

InvestingAug 7 11:56 ET

RBC Capital Remains a Hold on Sangamo Biosciences (SGMO)

TipRanksAug 7 07:17 ET · Ratings

Roche Strikes New Deal With Sangamo to Tackle Alzheimer's

Investing.com Aug 6 19:44 ET

Sangamo Therapeutics, Inc. (SGMO) Q2 2024 Earnings Call Transcript

Earnings Call TranscriptsAug 6 19:07 ET

Express News | Sangamo Therapeutics Expects FY24 GAAP Basis Total Operating Expenses Of Approximately $150M - $170M

BenzingaAug 6 17:57 ET